- Home
- RPRX vs TKO Comparison
RPRX vs TKO Comparison
Compare RPRX & TKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- TKO
- Stock Information
- Founded
- RPRX 1996
- TKO 1980
- Country
- RPRX United States
- TKO United States
- Employees
- RPRX N/A
- TKO N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- TKO
- Sector
- RPRX Health Care
- TKO
- Exchange
- RPRX Nasdaq
- TKO Nasdaq
- Market Cap
- RPRX 13.9B
- TKO 13.3B
- IPO Year
- RPRX 2020
- TKO N/A
- Fundamental
- Price
- RPRX $36.46
- TKO $177.14
- Analyst Decision
- RPRX Strong Buy
- TKO Strong Buy
- Analyst Count
- RPRX 3
- TKO 14
- Target Price
- RPRX $47.33
- TKO $163.77
- AVG Volume (30 Days)
- RPRX 4.4M
- TKO 988.9K
- Earning Date
- RPRX 08-07-2025
- TKO 08-07-2025
- Dividend Yield
- RPRX 2.42%
- TKO 0.86%
- EPS Growth
- RPRX 37.60
- TKO N/A
- EPS
- RPRX 2.45
- TKO 1.17
- Revenue
- RPRX $2,263,845,000.00
- TKO $2,850,693,000.00
- Revenue This Year
- RPRX $29.35
- TKO $61.11
- Revenue Next Year
- RPRX $7.58
- TKO $24.35
- P/E Ratio
- RPRX $14.83
- TKO $150.84
- Revenue Growth
- RPRX 1.13
- TKO 10.04
- 52 Week Low
- RPRX $24.05
- TKO $102.46
- 52 Week High
- RPRX $36.43
- TKO $182.60
- Technical
- Relative Strength Index (RSI)
- RPRX 64.64
- TKO 61.91
- Support Level
- RPRX $35.01
- TKO $172.66
- Resistance Level
- RPRX $36.33
- TKO $182.60
- Average True Range (ATR)
- RPRX 0.63
- TKO 4.31
- MACD
- RPRX 0.05
- TKO 0.30
- Stochastic Oscillator
- RPRX 90.72
- TKO 78.74
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About TKO TKO Group Holdings Inc.
TKO Group Holdings Inc is a sports and sports entertainment company that operates combat sport and sports entertainment companies. It owns and manages valuable sports and entertainment intellectual property. The company distributes content and monetizes its intellectual property through four principal activities: Media Rights and Content, Live Events, Sponsorship, and Consumer Products Licensing. The company has two reportable segments, UFC and WWE. The company generates the majority of its revenue from the UFC segment. The UFC segment revenue consists of media rights fees associated with the distribution of its programming content, ticket sales, and site fees associated with the business's global live events, sponsorship, and consumer products licensing agreements of UFC-branded products.